Elon Musk’s start-up for brain-computer interface (BCI) Neuralink has begun accepting applications for its first human trial. The company’s goal is to connect human brains to computers, and it plans to test its technology on paralysed people. A robot will assist in implanting a BCI that will allow them to control a computer cursor or type using only their thoughts. On the other hand, rival companies have already implanted BCI devices in humans.
In May, Neuralink received approval from the US Food and Drug Administration (FDA) for its first human clinical trial, a critical step after previous delays.
According to Neuralink, the FDA approval was “an important first step that will one day allow our technology to help many people.”
Technology News UK reports that Former and current employees told Reuters that the company had requested permission to implant its devices in ten people. The final agreed-upon figure has yet to be discovered.
Its goal is to assess the safety of Neuralink’s N1 implant and R1 surgical robot, as well as the initial functionality of the BCI, which will allow people with paralysis to control external devices using their thoughts.
 Neuralink has begun accepting applications for its first human trial.){kind=link}